TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is it Comeback Time?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to make deals and pay down debt. Is it time to reconsider investing?

    Read more »

    Investing

    Valeant Pharmaceuticals Intl Inc. Will Do Almost Anything to Lower Debt

    The latest asset sale by Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shows it’s fanatical about debt reduction, regardless of the possible…

    Read more »

    The Motley Fool
    Investing

    This Stock Has Nearly Doubled Since April: How Much Higher Can it Climb?

    Why my price target of $25 for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) still stands and, in fact, appears more likely…

    Read more »

    The Motley Fool
    Investing

    Why Is Valeant Pharmaceuticals Intl Inc. up 30% Since June 1?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has multiple debt-repayment strategies, but with shares up so much already, wait for a pullback.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. With Papa Is a Great Buy

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been a tough stock to own up until a few months ago. Here's why…

    Read more »

    Investing

    This 1 Company May Still Be the Best Contrarian Play of the Year

    Here's why Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may still be one of the best contrarian plays for 2017.

    Read more »

    The Motley Fool
    Investing

    Can Joe Papa Make Valeant Pharmaceuticals Intl Inc. a High Flyer Again?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is starting to look like a great contrarian play. Should you load up today?

    Read more »

    The Motley Fool
    Investing

    What’s the Next Stop for Valeant Pharmaceuticals Intl Inc.?

    With a little tailwind, investors still need to be cautious of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Will Donald Trump Give Valeant Pharmaceuticals Intl Inc. a Much-Needed Lifeline?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) stock jumped 28% this week. What’s brewing?

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. a Viable Investment Opportunity?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to chip away at a staggering amount of debt and transition to a more…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. vs. Jean Coutu Group PJC Inc.: Is the Drug Maker or Drug Retailer a Buy?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a drug producer, while Jean Coutu Group PJC Inc. (TSX:PJC.A) is a drug retailer.…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: When Is a Good Time to Invest?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to achieve its goal of paying down its debt, but there's a lot of…

    Read more »